Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
COCH Envoy Medical	$1.42 -2.7%	$1.50	$1.21 ▼ $3.99	$31.42M	2.21	14,727 shs	57,200 shs
FEMY Femasys	$0.71 -4.4%	$0.89	$0.69 ▼ $1.80	$24.18M	-2.58	241,846 shs	236,582 shs
HSCS HeartSciences	$3.38 -3.4%	$3.76	$2.36 ▼ $6.47	$7.97M	2.56	136,404 shs	84,226 shs
VVOS Vivos Therapeutics	$4.11 -10.8%	$4.30	$1.98 ▼ $7.95	$27.15M	7.03	172,569 shs	338,869 shs

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
COCH Envoy Medical	-2.74%	-7.19%	-12.35%	-15.48%	-48.55%
FEMY Femasys	-4.35%	-20.47%	-22.82%	-33.01%	-33.01%
HSCS HeartSciences	-3.43%	-5.85%	-14.43%	+3.68%	+1.50%
VVOS Vivos Therapeutics	-10.85%	-6.59%	-32.29%	+61.81%	+73.42%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
COCH Envoy Medical	3.4633 of 5 stars	3.5	5.0	2.7	3.3	0.0
FEMY Femasys	2.9712 of 5 stars	3.5	3.0	2.4	2.5	0.6
HSCS HeartSciences	3.369 of 5 stars	3.5	5.0	3.6	0.8	0.6
VVOS Vivos Therapeutics	1.4946 of 5 stars	2.3	4.0	2.4	0.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
COCH Envoy Medical	3.00	Buy	$9.25	551.41% Upside
FEMY Femasys	3.00	Buy	$7.33	932.72% Upside
HSCS HeartSciences	3.00	Buy	$13.00	284.62% Upside
VVOS Vivos Therapeutics	2.50	Moderate Buy	$4.82	17.19% Upside

Current Analyst Ratings Breakdown

Latest HSCS, COCH, FEMY, and VVOS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $8.00
6/25/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
6/11/2025	FEMY Femasys	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
5/27/2025	COCH Envoy Medical	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$9.25 ➝ $9.50
5/20/2025	VVOS Vivos Therapeutics	Industrial Alliance Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$2.25
5/20/2025	VVOS Vivos Therapeutics	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral

(Data available from 8/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
COCH Envoy Medical	$220K	138.90	N/A	N/A	($1.39) per share	-1.02
FEMY Femasys	$1.63M	14.19	N/A	N/A	$0.05 per share	14.20
HSCS HeartSciences	N/A	N/A	N/A	N/A	$0.18 per share	N/A
VVOS Vivos Therapeutics	$15.03M	1.61	N/A	N/A	$1.35 per share	3.04

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
COCH Envoy Medical	-$20.80M	-$1.43	N/A	N/A	N/A	-10,961.26%	N/A	-236.14%	N/A
FEMY Femasys	-$18.82M	-$0.86	N/A	N/A	N/A	-1,113.72%	-713.74%	-152.60%	N/A
HSCS HeartSciences	-$8.77M	-$9.36	N/A	N/A	N/A	N/A	-293.60%	-135.39%	9/11/2025 (Estimated)
VVOS Vivos Therapeutics	-$11.14M	-$1.73	N/A	N/A	N/A	-76.82%	-170.43%	-77.82%	N/A

Latest HSCS, COCH, FEMY, and VVOS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/11/2025	N/A	HSCS HeartSciences	-$2.41	N/A	N/A	N/A	N/A	N/A
8/8/2025	Q2 2025	FEMY Femasys	-$0.18	-$0.16	+$0.02	-$0.16	$0.80 million	$0.41 million
7/31/2025	Q2 2025	COCH Envoy Medical	-$0.29	-$0.32	-$0.03	-$0.32	$0.07 million	$0.08 million
7/24/2025	Q4 2025	HSCS HeartSciences	-$2.51	-$1.88	+$0.63	-$1.88	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
COCH Envoy Medical	N/A	N/A	N/A	N/A	N/A
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
HSCS HeartSciences	N/A	N/A	N/A	N/A	N/A
VVOS Vivos Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
COCH Envoy Medical	N/A	0.94	0.74
FEMY Femasys	0.03	0.89	0.54
HSCS HeartSciences	N/A	0.59	0.41
VVOS Vivos Therapeutics	N/A	0.77	0.77

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
COCH Envoy Medical	8.59%
FEMY Femasys	65.27%
HSCS HeartSciences	17.24%
VVOS Vivos Therapeutics	26.35%

Insider Ownership

Company	Insider Ownership
COCH Envoy Medical	58.90%
FEMY Femasys	11.54%
HSCS HeartSciences	1.80%
VVOS Vivos Therapeutics	3.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
COCH Envoy Medical	34	21.52 million	8.85 million	Not Optionable
FEMY Femasys	30	32.58 million	28.82 million	Not Optionable
HSCS HeartSciences	10	2.28 million	2.24 million	Not Optionable
VVOS Vivos Therapeutics	160	5.89 million	5.71 million	Optionable

HSCS, COCH, FEMY, and VVOS Headlines

Recent News About These Companies

Vivos Therapeutics Delays Q2 2025 10-Q Filing

August 14 at 11:30 PM | msn.com

Vivos Therapeutics (VVOS) Projected to Post Earnings on Wednesday

August 12, 2025 | americanbankingnews.com

Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Wall Street Zen

August 12, 2025 | americanbankingnews.com

Vivos Therapeutics Adds to Management Team to Support Expansion and Growth

July 30, 2025 | finance.yahoo.com

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance - Morningstar

July 2, 2025 | morningstar.comM

Vivos Therapeutics Inc. (VVOS) Stock Price Today - WSJ

July 2, 2025 | wsj.com

Vivos Therapeutics Receives Medicare Approval for VidaSleep™ Oral Appliance

July 1, 2025 | taiwannews.com.twT

Vivos Therapeutics stock soars after Medicare approves VidaSleep oral appliance

July 1, 2025 | in.investing.com

Vivos Therapeutics Shares Skyrocket After Medicare Greenlights VidaSleep Oral Device

July 1, 2025 | msn.com

Vivos Therapeutics Secures CMS Approval for VidaSleep™ Oral Appliance, Expanding Access to Sleep Apnea Treatment

July 1, 2025 | quiverquant.comQ

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26, 2025 | finance.yahoo.com

New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children

June 26, 2025 | globenewswire.com

Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finanznachrichten.de

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada

June 11, 2025 | finance.yahoo.com

Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada, Expanding OSA Diagnostic and Treatment Capabilities

June 11, 2025 | quiverquant.comQ

Vivos Therapeutics Secures $1.1M Convertible Note

May 23, 2025 | tipranks.com

Earnings call transcript: Vivos Therapeutics reports Q1 2025 earnings, stock rises

May 17, 2025 | uk.investing.com

Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

May 17, 2025 | finanznachrichten.de

Vivos Therapeutics Inc (VVOS) Q1 2025 Earnings Call Highlights: Strategic Acquisitions and FDA ...

May 17, 2025 | finance.yahoo.com

Vivos Therapeutics’ Earnings Call: Strategic Shifts Amid Financial Challenges

May 16, 2025 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

HSCS, COCH, FEMY, and VVOS Company Descriptions

Envoy Medical NASDAQ:COCH

$1.42 -0.04 (-2.74%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$1.44 +0.02 (+1.06%)

As of 08/15/2025 04:10 PM Eastern

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Femasys NASDAQ:FEMY

$0.71 -0.03 (-4.35%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$0.73 +0.02 (+3.22%)

As of 08/15/2025 07:01 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

HeartSciences NASDAQ:HSCS

$3.38 -0.12 (-3.43%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$3.38 0.00 (0.00%)

As of 08/15/2025 07:56 PM Eastern

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Vivos Therapeutics NASDAQ:VVOS

$4.11 -0.50 (-10.85%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$4.16 +0.04 (+1.09%)

As of 08/15/2025 07:53 PM Eastern

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time